Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018–2022 HIV vaccine preparedness cohort in Masaka, Uganda
PLOS One · 08.05.2026 · 21 (5) · e0348769
DOI: 10.1371/journal.pone.0348769 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.05.2026. Verfasst von Sylvia Kusemererwa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda. Hauptthemen laut MEDLINE: HIV Infections, AIDS Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership.
Abstract (Originalsprache)
Introduction
Despite global reports of declining HIV incidence, current data are limited. This study presents findings on HIV incidence and risk factors in a HIV trial preparedness cohort.
Methods
Between 18 July 2018 and 13 October 2022, individuals 18–45-year-old were recruited from communities along the trans-African highway and the shores of Lake Victoria in Masaka district, Uganda. Eligible individuals were HIV-negative and met at least one of the following criteria: suspected or confirmed sexually transmitted infection (STI), unprotected sex with ≥2 partners, unprotected sex with a new partner in the past 3 months, or unprotected sex in exchange for money/goods in the past month. Baseline data included demographics, sexual behaviour, and HIV risk factors. Follow-up assessments of HIV risk and sexual behaviour were conducted every six months, while HIV counselling and testing (HCT) were provided every 3 months, with linkage to care for those testing positive. Data were summarised descriptively, and associations with HIV incidence were analysed using uni-variable and multi-variable Poisson regression models.
Results
Of the 1422 individuals enrolled, 1115 (78.4%) attended ≥1 follow-up visit; 69% were female and 55% were aged ≤24 years. Over 900.3 person-years of observation (PYO), 24 individuals acquired HIV, yielding an incidence rate (IR) of 2.7 PYO [95% Confidence Interval (CI): 1.8–4.0]. Baseline factors independently associated with incident HIV included female sex [adjusted incidence rate ratio (aIRR) = 6.84 PYO, 95% CI 1.60–29.30], residence in a fishing community [aIRR = 3.04 PYO, 95% CI 1.05–8.78] and recreational drug use in the past 3 months [aIRR = 3.08 PYO, 95% CI 1.19–7.99]. In a separate analysis, using time-updated variables assessed during follow-up, HIV acquisition was associated with sex after alcohol consumption [aIRR = 2.65 PYO, 95% CI 1.11–6.31], and STI diagnosis/treatment within the past 3 months [aIRR = 2.52 PYO, 95% CI 1.09–5.80].
Conclusion
HIV incidence remains high among women, fishing community residents, and individuals with high risk behaviours, underscoring the need for targeted interventions to reduce the burden in these populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
- London School of Hygiene and Tropical Medicine, London, United Kingdom.
- King's College London, London, United Kingdom.
- Medical Research Council Clinical Trials Unit, London, United Kingdom.
ORCID-Profile: Sylvia Kusemererwa
Förderung
- European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Kusemererwa, S., Kansiime, S., Mutonyi, G., Kakande, A., Nabukenya, S., Namirembe, A., Erima, N., Asio, D. J., Atuhura, E. M., Ssendagire, S., Onyango, M., Fox, J., McCormack, S., Kaleebu, P., Ruzagira, E., & PrEPVacc Study Team (2026). Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018–2022 HIV vaccine preparedness cohort in Masaka, Uganda. PLOS One, 21(5), e0348769. https://doi.org/10.1371/journal.pone.0348769
Vancouver
Kusemererwa S, Kansiime S, Mutonyi G, Kakande A, Nabukenya S, Namirembe A, et al. Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018–2022 HIV vaccine preparedness cohort in Masaka, Uganda. PLOS One. 2026;21(5):e0348769. doi:10.1371/journal.pone.0348769
BibTeX
@article{Kusemererwa2026,
author = {Kusemererwa, Sylvia and Kansiime, Sheila and Mutonyi, Gertrude and Kakande, Ayoub and Nabukenya, Shamim and Namirembe, Aeron and Erima, Naphtal and Asio, Doreen Joan and Atuhura, Elizabeth Mbabazi and Ssendagire, Shamim and Onyango, Martin and Fox, Julie and McCormack, Sheena and Kaleebu, Pontiano and Ruzagira, Eugene and PrEPVacc Study Team, PrEPVacc Study Team},
title = {Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018–2022 HIV vaccine preparedness cohort in Masaka, Uganda},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348769},
doi = {10.1371/journal.pone.0348769}
}
EUVIMED